The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 286.00
Bid: 286.50
Ask: 291.00
Change: 22.50 (8.54%)
Spread: 4.50 (1.571%)
Open: 262.00
High: 295.00
Low: 262.00
Prev. Close: 263.50
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q4 and FY trading update

20 Jan 2017 07:00

RNS Number : 6689U
Synthomer PLC
20 January 2017
 

Official Entity Name: SYNTHOMER PLC

LEI: 213800EHT3TI1KPQQJ56

 

20 January, 2017

 

Synthomer plc

 

Q4 and FY trading update

 

Synthomer plc ('Synthomer' or 'the Group') today issues a trading update for the year ended 31 December 2016.

 

Europe and North America

The positive trends experienced in our Europe and North America business during the first three quarters of the year continued through Q4 leading to an overall performance ahead of our original expectations. We saw better than expected results across all business segments and further benefits from the ongoing focus on efficiency, new product initiatives, a strengthened procurement function and investment in business development activities.

 

Asia and Rest of World

Asia and Rest of World also performed modestly ahead of our expectations in Q4 with the competitive dynamics in our Asian Nitrile business continuing to evolve following the introduction of additional industry capacity in the second half of the year. Full year 2016 volumes and margins for this business are now likely to be sequentially ahead of FY 2015.

 

Hexion PAC

The integration and trading performance of Hexion PAC continues to progress in line with our expectations. The underlying annual EBITDA and expected synergies remain unchanged from the guidance given to the market in March 2016.

 

Full Year 2016

Due to the combination of a stronger trading performance in Europe and a slower evolution of the Asian Nitrile dynamics during Q4, we now expect 2016 performance on an underlying constant currency basis to be ahead of the top end of current market expectations.(1)

 

In addition, the Group will also benefit from the translation effect related to the ongoing weakness of sterling. Average YTD FX rates were €1.22 and $1.35, and are expected to provide a translational benefit of approximately £12m for the full year.

 

In reported currency, taking into account both these factors, the Board now anticipates that FY 2016 PBT will be approximately £120m.

 

2017 outlook

Looking forward to 2017, we still expect to see resilient trading in Europe although the raw material and macroeconomic environments remain volatile. We also expect our Asian Nitrile business to be further impacted by the introduction of the additional industry capacity in 2016. This will be partially offset by a full year of Hexion PAC included in the Group's results.

 

The Group will provide further detail on the outlook for 2017 with its 2016 Full Year results on 6 March 2017.

 

1. FY 2016 Consensus: Constant Currency Profit before Tax between £92.0m - £103.9m with consensus at £98.3m (Compiled by Teneo Blue Rubicon)

 

-ENDS-

 

Enquiries:

Stephen Bennett, Chief Financial Officer +44 1279 775 250

Charles Armitstead, Teneo Blue Rubicon +44 203 603 5220

 

The Company will hold a conference call for investors and analysts at 0900 BST today.

Please dial +44 (0) 808 237 0030 entering conference ID: 61421287# to gain access to the call.

 

The Company considers this announcement to contain inside information

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTFMGMMRLZGNZM
Date   Source Headline
24th Jul 20194:34 pmRNSDirector Declaration
15th Jul 20197:00 amRNSAdmission of Nil Paid Rights
10th Jul 20191:49 pmRNSPublication of Circular and Prospectus
10th Jul 20191:34 pmRNSDirector/PDMR Shareholding
3rd Jul 20197:00 amRNSAcquisition
2nd Jul 20193:56 pmRNSDirector Declaration
13th Jun 201911:18 amRNSDirector Declaration
25th Apr 20194:45 pmRNSResult of AGM
25th Apr 20197:00 amRNSQ1 Trading Update
10th Apr 20194:51 pmRNSDirector/PDMR Shareholding
10th Apr 20194:50 pmRNSDirector/PDMR Shareholding
10th Apr 20194:43 pmRNSDirector/PDMR Shareholding
10th Apr 20194:41 pmRNSDirector/PDMR Shareholding
28th Mar 20193:51 pmRNSDirector/PDMR Shareholding
28th Mar 20193:50 pmRNSDirector/PDMR Shareholding
25th Mar 20193:15 pmRNSAnnual Financial Report
21st Mar 20193:39 pmRNSDirector Declaration
18th Mar 201910:02 amRNSDirector/PDMR Shareholding
12th Mar 201911:25 amRNSDirector/PDMR Shareholding
12th Mar 201911:23 amRNSDirector/PDMR Shareholding
5th Mar 20194:09 pmRNSDirector/PDMR Shareholding
4th Mar 20197:00 amRNSResults for the year ended 31 December 2018
1st Mar 20193:26 pmRNSDirector Declaration
3rd Dec 201810:54 amRNSHolding(s) in Company
9th Nov 201811:36 amRNSDirector/PDMR Shareholding
6th Nov 20187:00 amRNSQ3 Trading update
17th Oct 20189:29 amRNSDirector Declaration
21st Sep 20189:17 amRNSDirectorate Change
6th Aug 20187:00 amRNSResults for the six months ended 30 June 2018
11th Jul 20186:25 pmRNSDirector/PDMR Shareholding
10th Jul 20189:47 amRNSHolding(s) in Company
4th Jul 201811:45 amRNSHolding(s) in Company
4th Jul 201811:44 amRNSHolding(s) in Company
4th Jul 201811:43 amRNSHolding(s) in Company
28th Jun 20183:12 pmRNSUpdate on Proposed Offering
25th Jun 20187:19 amRNSPROPOSED OFFERING OF EUR300M BOND & REFINANCING
21st Jun 201810:16 amRNSResult of Extraordinary General Meeting
8th Jun 20187:00 amRNSEuropean Commission investigation
4th Jun 20181:02 pmRNSNotice of GM
3rd May 20181:38 pmRNSHolding(s) in Company
2nd May 20184:29 pmRNSDirector/PDMR Shareholding
26th Apr 20182:23 pmRNSResult of AGM
26th Apr 20187:00 amRNSQ1 Trading update
9th Apr 20184:54 pmRNSDirector Declaration
27th Mar 20181:03 pmRNSDirector/PDMR Shareholding
27th Mar 20181:01 pmRNSDirector/PDMR Shareholding
26th Mar 20184:55 pmRNSAnnual Financial Report
8th Mar 20184:39 pmRNSDirector/PDMR Shareholding
8th Mar 20184:37 pmRNSDirector/PDMR Shareholding
5th Mar 20182:43 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.